Motivational Interviewing to Support Oral AntiCoagulation Adherence in Patients With Non-valvular Atrial Fibrillation (MISOAC-AF) (MISOAC-AF)
Patient Compliance, Patient Adherence
About this trial
This is an interventional supportive care trial for Patient Compliance focused on measuring atrial fibrillation, oral anticoagulation, motivational intervention, adherence, treatment gaps
Eligibility Criteria
Inclusion Criteria:
- Age over 18 years
- Patients with comorbid non-valvular AF, defined on the basis of physician-assigned diagnoses during the hospitalization or as previously documented in the medical record, and additionally documented on an electrocardiogram or 24-h Holter monitor, if available.
- Patients that receive OAC at hospital discharge or are eligible for OAC therapy (CHA2DS2-VASc score ≥1 for males and ≥2 for females).
Exclusion Criteria:
- Patients unable to communicate via telephone for study interviewing
- Patients with any medical disorder that would interfere with completion or evaluation of clinical study results
- Patients that lived in assisted-care facilities or had terminal illness.
- Presence of metallic valves or moderate-to-severe mitral stenosis
Anticoagulated patients on an intentionally short-term OAC prescription under physician's recommendations (i.e. lone recent AF episode) will be excluded.
Sites / Locations
- AHEPA University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Subject on Motivational Interview
Subject Control
Motivational Interview - Baseline: At hospital discharge, patients assigned to the intervention group will be contacted in person by a study physician for an interactive session and will be given an educational leaflet. Both methods will aim to educate them about the risk for stroke and the importance of adherence to OAC medication. The leaflet will also provide some basic information on how to take OAC medication (doses, food interactions, skipping doses, etc.) and will describe the main clinical manifestations of side effects. Motivational Interview - Follow-up: Patients assigned to the intervention group will be contacted via telephone for a pre-specified interview at 1 week, 2 months, 6 months and 1 year after discharge. The delegated study personnel will assess whether an intervention is required and provide specific support tailored to the needs of the patient, aiming to improve adherence to OAC.
Patients assigned to the control group will receive usual treatment and will be contacted via telephone for a pre-specified interview at 1 year after discharge for outcome assessment.